MedPath

Melatonin effect in Stroke patients

Phase 3
Conditions
hemorrhagic stroke.
Intracerebral haemorrhage, unspecified
I.61.9
Registration Number
IRCT201610225073N2
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients who are admitted to ICU within 72 hours of hemorrhagic stroke
Exclusion criteria:
hepatic failure; brain tumor; Melatonin hypersensitivity; Rhomatologic or autoimmune diseases

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath